191 filings
Page 3 of 10
8-K
xmvnqgbg10qdm6 xb
14 Jun 23
Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-market Under Nasdaq Rules
4:11pm
424B5
h2zl0
13 Jun 23
Prospectus supplement for primary offering
8:02am
424B3
r1rgpq9s
13 Jun 23
Prospectus supplement
8:00am
8-K
3bjm2
8 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
gyyfuieo
15 May 23
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
ARS
6lyy a6wsow92qhht4z
27 Apr 23
Annual report to shareholders
4:36pm
DEFA14A
rrgfkg7
27 Apr 23
Additional proxy soliciting materials
4:32pm
8-K
rebdaa 9afs
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
g1d 9omle
30 Mar 23
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
4:06pm
8-K
8zog 651plf727d068n
13 Mar 23
Regulation FD Disclosure
6:08am
EFFECT
j7wbf00lbx
8 Feb 23
Notice of effectiveness
12:15am
CORRESP
qu251 nd7
3 Feb 23
Correspondence with SEC
12:00am
UPLOAD
a9bgo
1 Feb 23
Letter from SEC
12:00am
8-K
98h63b qgxp4
20 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
e7gwjx
12 Jan 23
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
6:06am
8-K
jz0gm3
9 Jan 23
Material Modifications to Rights of Security Holders
4:02pm